An exploratory study on the molecular biological characteristics of lower extremity atherosclerosis using directional coronary artery atherectomy and single-cell analysis

Otake Hiromasa0 个研究点目标入组 12 人开始时间: 2023年7月3日最近更新: 2023年10月17日

试验速览

暂无简介。

•(1) LEAD patients scheduled to undergo elective EVT for femoropopliteal or below-knee ar
•tery lesions
•(2) Patients whose lesions to be treated were determined to be non-calcified lesions
•(3) Patients with lesions >4 mm in reference vessel diameter on preoperative angiography or CT examination
•(4) Patients who are 18 years of age or older at the time of informed consent
•(5) Patients who can understand the content of the treatment and the purpose of the research, and
•who are able to obtain written informed consent of their own free will.

•(1) Patients with acute limb ischemia or acutethrombosis
•(2) In-stent stenosis or occlusive lesion
•(3) Rutherford Category 6, or Critical limb ischemia suspected of widespread infection
•(4) Patients who find it difficult to continue antiplatelet therapy (such as patients planning surgery that requires withdrawal of antiplatelet agents within one month)
•(5) Patients who are pregnant/lactating or may be pregnant
•(6) Other patients who are judged inappropriate by the principle investigator or subinvestigator

发起方

Otake Hiromasa